|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Hormonal contraception and risk of cervical infections among HIV-1- |
| seropositive Kenyan women. |
| Lavreys L; Chohan V; Overbaugh J; Hassan W; McClelland RS |
| The objective was to evaluate the relationship between hormonal contraceptive use and the acquisition of cervical |
| sexually transmitted infections (STI) among HIV-1-infected women. A prospective cohort study of 242 commercial |
| sex workers in Mombasa, Kenya, followed from the time of HIV-1 infection. At monthly follow-up visits, sexual |
| behavior and contraceptive use were recorded, and laboratory screening for STI was performed. Multivariate |
| Andersen-Gill proportional hazards models were constructed to examine the association between the use of |
| hormonal contraception and the occurrence of cervical STI. The median duration of follow-up after HIV-1 acquisition |
| was 35 months, and 799 person-years of follow-up were accrued. After adjustment for demographic factors and |
| sexual behavior, women using the injectable contraceptive depot medroxyprogesterone acetate were at increased risk |
| of Chlamydia trachomatis infection [hazard ratio (HR) 3.1, 95% confidence interval (CI) 1.0-9.4, P = 0.05] and |
| cervicitis (HR 1.6, 95% CI 1.0-2.3, P = 0.03) compared with women using no contraception. The use of oral |
| contraceptive pills was associated with an increased risk of cervicitis (HR 2.3, 95% CI 1.4-3.8, P = 0.001). Hormonal |
| contraception was not associated with an increased risk of infection with Neisseria gonorrhoeae. The use of |
| hormonal contraception by HIV-1-infected women was associated with an increased risk of cervicitis and cervical |
| chlamydia infection. HIV-1- seropositive women using hormonal contraception should be counseled about the |
| importance of consistent condom use to prevent both STI and HIV-1 transmission. (PubHealth.info Document ID: |
| PubHealth.info NOTE: The author(s) of this article titled, "Hormonal contraception and risk of cervical infections |
| among HIV-1-seropositive Kenyan women.", is(are) Lavreys L; Chohan V; Overbaugh J; Hassan W; McClelland |
| RS. The source of this article is "AIDS. 2004;18:2179-2184.". This article was published in 2004 in English |
| language(s). (PubHealth.info® Document ID: CONT1T 566-06. All rights reserved with PubHealth.info) PIN: 566 |
| This article is peer-reviewed. |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |